Identification of Chemical Scaffolds That Inhibit the Mycobacterium tuberculosis Respiratory Complex Succinate Dehydrogenase
- 13 September 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 10 (10) , 3496-3515
Abstract
Drug-resistant Mycobacterium tuberculosis is a significant cause of infectious disease morbidity and mortality for which new antimicrobials are urgently needed. Inhibitors of mycobacterial respiratory energy metabolism have emerged as promising next-generation antimicrobials, but a number of targets remain unexplored. Succinate dehydrogenase (SDH), a focal point in mycobacterial central carbon metabolism and respiratory energy production, is required for growth and survival in M. tuberculosis under a number of conditions, highlighting the potential of inhibitors targeting mycobacterial SDH enzymes. To advance SDH as a novel drug target in M. tuberculosis, we utilized a combination of biochemical screening and in-silico deep learning technologies to identify multiple chemical scaffolds capable of inhibiting mycobacterial SDH activity. Antimicrobial susceptibility assays show that lead inhibitors are bacteriostatic agents with activity against wild-type and drug-resistant strains of M. tuberculosis. Mode of action studies on lead compounds demonstrate that the specific inhibition of SDH activity dysregulates mycobacterial metabolism and respiration and results in the secretion of intracellular succinate. Interaction assays demonstrate that the chemical inhibition of SDH activity potentiates the activity of other bioenergetic inhibitors and prevents the emergence of resistance to a variety of drugs. Overall, this study shows that SDH inhibitors are promising next-generation antimicrobials against M. tuberculosis.Keywords
Funding Information
- Ministry of Health, New Zealand (82061128001)
- Maurice Wilkins Centre for Molecular Biodiscovery
- National Natural Science Foundation of China (NSFC 82061128001)
- China-Maurice Wilkins Centre Biomedical Collaboration Fund
This publication has 113 references indexed in Scilit:
- Crystallographic investigation of the ubiquinone binding site of respiratory Complex II and its inhibitorsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2021
- Alternate quinone coupling in a new class of succinate dehydrogenase may potentiate mycobacterial respiratory controlFEBS Letters, 2019
- Unpacking the Pathogen Box—An Open Source Tool for Fighting Neglected Tropical DiseaseChemMedChem, 2019
- Biochemical studies of membrane bound Plasmodium falciparum mitochondrial L-malate:quinone oxidoreductase, a potential drug targetBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2018
- A spectrophotometric coupled enzyme assay to measure the activity of succinate dehydrogenaseAnalytical Biochemistry, 2013
- Defining a direction: Electron transfer and catalysis in Escherichia coli complex II enzymesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2013
- The di-heme family of respiratory complex II enzymesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2013
- Fueling Open‐Source Drug Discovery: 177 Small‐Molecule Leads against TuberculosisChemMedChem, 2013
- Ferulenol specifically inhibits succinate ubiquinone reductase at the level of the ubiquinone cycleBiochemical and Biophysical Research Communications, 2007
- Inhibition of mammalian succinate dehydrogenase by carboxinsArchives of Biochemistry and Biophysics, 1977